FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2018

POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
SURGICAL ONCOLOGY
PAPER-III
SURONC/J/18/47/III
Time: 3 hours
Max. Marks:100
Important Instructions:
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space
Answer all the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. Management of well differentiated thyroid cancer in the context
of American Thyroid Association 2015 Guidelines.
10
2. Superior vena cava syndrome
Psuedomyxoma peritonii
Incidentally detected gallbladder cancer

3. Management of regionally metastatic cutaneous melanoma.
Recent advances in treatment of melanoma.
7+3
4. Concept of sentinel node biopsy in solid organ malignancies.
Discuss in brief the techniques and current applications with
level 1 evidence for each organ where it is performed.

5. How do you classify pancreatic cancers based on criteria for
resectability? What is "Artery first approach" for pancreatic head
resection? Discuss briefly different methods, advantages and
disadvantages.

6. Discuss the basis and current role of different molecular
diagnostic assays available for prognosticating early breast
cancer. Discuss the advances in treatment of triple negative
breast cancer.
6+4
7. Mechanism and role of different radiopharmaceuticals used in
the diagnosis and management of common solid organ
malignancies.
10
8. Discuss role and extent of surgery in carcinoma of the uterine
cervix. Add a note on early diagnosis and prevention of cervical
cancer.

9. Discuss the National Programme for Prevention and Control of
Cancer, Diabetes, Cardiovascular diseases and Stroke
(NPCDCS) and Tertiary Care Cancer Centers and State Cancer
Institutes under it.
10
P.T.O.
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2018

POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
10. Management of a T4bN2M0, ER/PR positive, Her 2 neu
breast cancer in a 40-year-old lady under the context of latest
available evidence.
10